Related Experiment Video
Updated: Oct 9, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics
Plinio A Trinidad-Calderón1, Carlos Daniel Varela-Chinchilla1, Silverio García-Lara1
1Tecnológico de Monterrey, School of Engineering, and Sciences, Avenida Eugenio Garza Sada 2501, Monterrey 64849, Nuevo León, Mexico.
Abstract:
Nowadays, cancer has become the second highest leading cause of death, and it is expected to continue to affect the population in forthcoming years. Additionally, treatment options will become less accessible to the public as cases continue to grow and disease mechanisms expand. Hence, specific candidates with confirmed anticancer effects are required to develop new drugs. Among the novel therapeutic options, proteins are considered a relevant source, given that they have bioactive peptides encrypted within their sequences. These bioactive peptides, which are molecules consisting of 2-50 amino acids, have specific activities when administered, producing anticancer effects. Current databases report the effects of peptides. However, uncertainty is found when their molecular mechanisms are investigated. Furthermore, analyses addressing their interaction networks or their directly implicated mechanisms are needed to elucidate their effects on cancer cells entirely. Therefore, relevant peptides considered as candidates for cancer therapeutics with specific sequences and known anticancer mechanisms were accurately reviewed. Likewise, those features which turn certain peptides into candidates and the mechanisms by which peptides mediate tumor cell death were highlighted. This information will make robust the knowledge of these candidate peptides with recognized mechanisms and enhance their non-toxic capacity in relation to healthy cells and further avoid cell resistance.
Insights
Bioactive peptides derived from proteins show promise as novel anticancer drugs. This review highlights specific peptide candidates and their tumor-killing mechanisms, crucial for developing effective cancer therapies.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology
- Oncology
Background:
- Cancer is a leading cause of death, with growing incidence and complex mechanisms necessitating novel therapeutic strategies.
- Proteins contain encrypted bioactive peptides with demonstrated anticancer effects, offering a promising avenue for drug development.
- Existing research on peptide therapeutics lacks detailed molecular mechanism insights and interaction network analyses.
Purpose of the Study:
- To review specific bioactive peptides with confirmed anticancer effects and known molecular mechanisms.
- To identify key features that qualify peptides as therapeutic candidates for cancer treatment.
- To elucidate the mechanisms by which these peptides induce tumor cell death.
Main Methods:
- Literature review of scientific databases and research articles.
- Analysis of peptide sequences and their reported anticancer activities.
- Investigation of documented molecular mechanisms underlying peptide-mediated cancer cell death.
Main Results:
- Several specific bioactive peptides with confirmed anticancer properties were identified.
- Key features contributing to peptide efficacy, including sequence and structure, were highlighted.
- Mechanisms of tumor cell death induced by these peptides, such as apoptosis and cell cycle arrest, were detailed.
Conclusions:
- Bioactive peptides represent a significant source for developing novel, targeted cancer therapeutics.
- Understanding peptide mechanisms is vital for optimizing efficacy and minimizing toxicity to healthy cells.
- Further research into peptide interaction networks can enhance their therapeutic potential and overcome drug resistance.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
The Intrinsic Apoptotic Pathway
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...